Pharmaceutical

Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024

LAVAL, QC / ACCESSWIRE / May 17, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix…

7 months ago

Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting

SEATTLE and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…

7 months ago

Recce Pharmaceuticals Doses First Participants in Next Cohort of Phase I/II Urinary Tract Infections and Urosepsis Rapid Infusion Clinical Trial

First participants (male/female) dosed at 4,000mg over 20 minutes, with remaining subjects to be dosed in the near future -…

7 months ago

Aeterna Zentaris Announces Details Regarding Transaction with Ceapro

TORONTO, ON, May 17, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) announces…

7 months ago

Akanda Corp. Receives Notice of Non-Compliance from NASDAQ

London, United Kingdom--(Newsfile Corp. - May 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), announced that it…

7 months ago

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patientsManassas, Virginia--(Newsfile Corp. -…

7 months ago

FSD Pharma Provides Update on Celly Nu’s New Packaging for unbuzzd(TM)

TORONTO, ON / ACCESSWIRE / May 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way…

7 months ago

CNS Pharmaceuticals Reports First Quarter 2024 Financial Results

Enrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025Company committed to addressing…

7 months ago

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

The Glinka family invested $4.5 million into Nutriband through the Company's April 2024 private placementORLANDO, FL / ACCESSWIRE / May…

7 months ago

Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development

NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Turbine, a predictive simulation company that…

7 months ago